Clinical trials recruiting for Alzheimer Dementia
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CpG1018 | 1 |
| Donepezil hydrochloride tablets | 1 |
| Huperzine A Controlled-Release Tablets | 1 |
| Levetiracetam 500mg | 1 |
| Low Dose Radiation Therapy | 1 |
| Methylphenidate (MPH) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
| New York | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
- Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
- Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
- Environmental Pollutants and Neurological Disorders
- Innate Immunity Stimulation Via TLR9 in Early AD
- LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
- Low-Dose Radiotherapy for Alzheimer's Disease
- The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Related conditions
Trials recruiting for Alzheimer Dementia often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Alzheimer Dementia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.